Etamsylate

DB13483InvestigationalSmall molecule

Etamsylate is a hemostatic agent that acts by restoring capillary resistance and improving platelet adhesion. A medication used to stop bleeding.

Chemical structure of Etamsylate
Mechanism
Curator reviewed
Formula / weight
C10H17NO5S · 263.31 g/mol (avg)
Also known as
Ethamsylate
Code names
E 141 · MD-141

Resolves to

Compound
UNII24YL531VOHCAS2624-44-4ChEMBLCHEMBL1514715ChEBI31563
Clinical / RWD
RxNorm4112ATCB02BX01
Structure
InChIKeyHBGOLJKPSFNJSD-UHFFFAOYSA-NSMILESCCNCC.OC1=CC(=C(O)C=C1)S(O)(=O)=O
Targets
P09038FGF2

What you can answer from here — as of August 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
6ContraindicationsEach with its own population and attribute set
Sign in
12Marketed productsAcross 3 countries and 8 labellers
Sign in
1ATC codeIncluding every combination product, plus 11 drug categories
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Etamsylate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In